Amryt Pharma plc - stock earnings
Stock symbol AMYT is outdated, potentially delisted? Maybe it is available on other exchange?
AMYT Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q3 | -20.8 million USD | 61.1 million USD |
| 2022Q2 | -7.0 million USD | 68.5 million USD |
| 2022Q1 | -14.5 million USD | 59.1 million USD |
| 2021Q4 | 41.5 million USD | 54.8 million USD |
| 2021Q3 | -17.2 million USD | 56.5 million USD |
| 2021Q2 | -6.8 million USD | 62.8 million USD |
| 2021Q1 | -16.5 million USD | 48.4 million USD |
| 2020Q4 | -47.0 million USD | 42.5 million USD |
| 2020Q3 | -10.5 million USD | 49.3 million USD |
AMYT Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | 1.0 million USD | 222.5 million USD |
| 2020 | -104.5 million USD | 182.6 million USD |
| 2019 | -63.0 million USD | 58.1 million USD |
| 2018 | -30.5 million USD | 17.1 million USD |
AMYT
Price: $14.70
52 week price:
Earnings Per Share: -0.03 USD
P/E Ratio: 39.73
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 151428
Market Capitalization: 937.0 million